Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
Open-market buys, last 90 days
$9,919,161,281
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Portman David J. +$9.9B 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-05-20 EDELMAN JOSEPH Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2022-05-20 FLUKE JOHN M JR Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2022-05-20 JOHNSON JAMES A Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2022-05-20 Panzara Michael A. Director Grant or award · Stock Option (Right to Buy) +2,311 2,311
2022-05-20 PERCEPTIVE ADVISORS LLC Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2022-05-18 Worthington Mark General Counsel Grant or award +3,396 $7.06 $24K 11,711
2022-05-18 MOEBIUS HANS Chief Medical Officer Grant or award +1,699 $7.06 $12K 32,955
2022-05-18 MILESON GLENNA Chief Financial Officer Grant or award +1,721 $7.06 $12K 101,781
2022-05-18 Litton Mark James Chief Executive Officer Grant or award +757 $7.06 $5K 116,515
2022-05-18 CHURCH KEVIN Executive VP, Research Grant or award +243 $7.06 $2K 47,809
2022-04-11 MILESON GLENNA Chief Financial Officer Exercise or conversion +3,000 $10.64 $32K 100,060
2022-04-11 MILESON GLENNA Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −3,000 167,000
2022-03-31 Romano Kelly A Director Purchase +8,000 $13.11 $105K 8,315
2022-03-18 Panzara Michael A. Director Grant or award · Stock Option (Right to Buy) +27,742 27,742
2022-02-18 CHURCH KEVIN Executive VP, Research Exercise or conversion +3,152 $1.19 $4K 47,566
2022-02-18 CHURCH KEVIN Executive VP, Research Exercise or conversion · Stock Option (Right to Buy) −3,152 0
2022-01-27 Litton Mark James Chief Executive Officer Grant or award · Stock Option (Right to Buy) +400,000 400,000
2022-01-27 PICKERING GRANT Director Grant or award · Stock Option (Right to Buy) +27,742 27,742
2022-01-18 Lenington Rachel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +180,000 180,000
2022-01-18 MILESON GLENNA Chief Financial Officer Grant or award · Stock Option (Right to Buy) +170,000 170,000

Page 14 of 18 · 349 trades